CIDP (chronic inflammatory demyelinating polyneuropathy) trials in Australia

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Taking people
  Efficacy and Safety Study of Nipocalimab for Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Where

  Melbourne, Parkwood

  Age

  18 years and over

  People

  201 worldwide

  Run by

  Janssen Research & Development, LLC

  See details and how to joinNCT05327114 · EU 2023-508425-28-00
• Phase 3Taking people
  A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP

  Where

  Liverpool

  Age

  18 years and over

  People

  218 worldwide

  Run by

  argenx

  See details and how to joinNCT06920004 · EU 2024-520097-36-00
• Phase 3Taking people
  A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)

  Where

  Liverpool, Melbourne, Randwick, Saint Leonards, Southport, Sydney

  Age

  18 years to 75 years

  People

  256 worldwide

  Run by

  Dianthus Therapeutics

  See details and how to joinNCT06858579
• Phase 1Taking people
  Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment

  Where

  Sydney, Westmead

  Age

  18 years to 75 years

  People

  57 worldwide

  Run by

  Kite, A Gilead Company

  See details and how to joinNCT07304154
• Phase 2Taking people
  Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

  Where

  Macquarie Park, Parkville, Woolloongabba

  Age

  18 years and over

  People

  162 worldwide

  Run by

  Immunovant Sciences GmbH

  See details and how to joinNCT07032662 · EU 2024-517614-14-00